Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients
This study is currently recruiting participants.
Verified December 2012
by Il-Yang Pharm. Co., Ltd.
Study NCT01511289 Information provided by Il-Yang Pharm. Co., Ltd.
First Received on January 3, 2012. Last Updated on December 27, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bone Marrow Diseases
Additional conditions recognized in this trial
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
More general conditions related to this trial
Neoplasms by Histologic Type
Interventions listed in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Protein Kinase Inhibitors
Sponsors listed in this trial
Il-Yang Pharm. Co., Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers